What do you know about transboundary animal diseases What do you know about transboundary animal diseases Transboundary animal diseases (TADs) are highly transmissible diseases of livestock that can impact veterinary public health preparedness.
REACH / GHS / Material safety data sheets REACH / GHS / Material safety data sheets We are continuously working on these topics with the aim to be in compliance with requirements deriving from these legislations.
Boosting performance with an inclusive performance culture Boosting performance with an inclusive performance culture Boosting performance of organizations with an inclusive performance culture
founding-member-of-QUTAC founding-member-of-QUTAC Together, the members of this newly founded consortium want to explore industrial applications for quantum computing
Are combination therapies the answer to battling KRAS cancers? Are combination therapies the answer to battling KRAS cancers? Dr Ulrich Dünzinger and Kristie Fernamberg talk about their work with the SOS1 KRAS inhibitor to block tumour-triggering signal
The big, the bold, and the few The big, the bold, and the few In the animal health industry, fewer players are vying for bigger market shares. What does that mean for companies, veterinarians, and consumers?
Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD FDA Grants nintedanib Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
EMA filing acceptance and validation for spesolimab EMA filing acceptance and validation for spesolimab The European Medicines Agency has accepted and validated the marketing authorization application for spesolimab in generalized pustular psoriasis
Innovation from within Innovation from within Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
collaboration-proxygen-molecular-glue-degraders collaboration-proxygen-molecular-glue-degraders Boehringer Ingelheim collaborates with Proxygen to explore molecular glue degraders – a novel approach to fight cancer.
biolabs-heidelberg biolabs-heidelberg Boehringer Ingelheim supports the launch of BioLabs first European Location in Heidelberg.
A career at the intersection of science and marketing A career at the intersection of science and marketing A member of the Animal Health digital marketing team, our colleague Missy talks about her purpose to bring transformative technologies to the vet community
European_Commission_approves_nintedanibSSc-ILD European_Commission_approves_nintedanibSSc-ILD Nintedanib is approved as the first and only treatment of systemic sclerosis-associated interstitial lung disease
additional-investment-in-Lyon-Jonage additional-investment-in-Lyon-Jonage Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France
Boehringer Ingelheim appointment to Board Managing Directors Boehringer Ingelheim appointment to Board Managing Directors Boehringer Ingelheim announces appointments to Board of Managing Directors
Boehringer Ingelheim announces appointments Boehringer Ingelheim announces appointments Boehringer Ingelheim announces appointments
Overcoming heartworm disease for homeless pets Overcoming heartworm disease for homeless pets Heartworm-free pets soar to new lives. Together with our Greater Good Charity partners, our colleagues helped bring shelter dogs to forever homes.
SPEVIGO (spesolimab) wins 2023 Prix Galien USA Award SPEVIGO (spesolimab) wins 2023 Prix Galien USA Award SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award